Boult Wade Tennant
Bulletins » Public Prior Use: What Can the Skilled Person See?

It is a well-known principle under UK patent law that any subject matter that the public can access without breaching a duty of confidentiality is considered to have been publicly disclosed, irrespective of whether anyone has actually accessed that subject matter. A disclosure which is in reality seen by no-one can therefore invalidate a subsequent patent application. A recent case in the Intellectual Property Enterprise Court (Claydon Yield-O-Meter Ltd v Mzuri Ltd [2021] EWHC 1007 (IPEC)) has provided some further applications of this principle.

As discussed in Lux Traffic Controls Ltd v Pike Signals Ltd ([1993] RPC 107) a book on a shelf of a library which is open to the public is considered a public disclosure. The contents of the book are considered disclosed “whether or not anybody read the book and whether or not it was situated in a dark and dusty corner of the library”. More recently though, in E. Mishan & Sons Inc v Hozelock Ltd [2019] EWHC 991 (Pat) it was decided that the inventor’s testing of a prototype garden hose in his garden, the garden being visible from a public road, was not an enabling disclosure because the judge accepted that the inventor would have hidden the prototype from view if anyone had tried to observe him. The questions of what the inventor would have done and what the skilled person could have seen if they were actually present were therefore key in that case to determining whether the subject matter had been disclosed.

In Claydon Yield-O-Meter Ltd v Mzuri Ltd., similarly to E. Mishan & Sons Inc v Hozelock Ltd, the inventor had tested a prototype of their invention, before filing their patent application, on private land that was visible from a public footpath. However, in this case the testing was of a large piece of agricultural machinery pulled behind a tractor in a field.

Amongst other things, the arguments in this case considered whether or not the inventor would have been able to effectively hide the relevant parts of the prototype from a person appearing on the public footpath and what the skilled person would have been able to determine about the invention from the marks left in the soil by the prototype, The judgement noted: “preventing a member of the public from seeing a prototype seed drill would have been a good deal more difficult than hiding a prototype garden hose….” The judgement also questioned whether the inventor could accurately state what they would have done if a member of the public had appeared given the length of time (nearly 20 years) since the testing had occurred. Ultimately, the testing of the prototype was considered to be a prior public use constituting an enabling disclosure of the invention, and so the claim in question was deemed invalid.

This case highlights the dangers inherent in testing prototypes in publicly-visible locations. It is clear that it will not always be possible to rely on an assertion that the device would have been hidden if a member of the public had been present. It seems that UK courts will take a practical view of what the skilled person could have seen in the specific circumstances in question, not only of the tested prototype itself but of any results of that test which would be visible to the skilled person had they passed by at the right moment.

If you have any questions, your usual Boult Wade Tennant advisor will be happy to assist you.

Relevant sectors
Aerospace
  • Commercial aviation
  • Defence and security
  • Space and satellites
  • Unmanned aerial vehicles
Artificial Intelligence and Machine Learning
Automotive
  • Autonomous vehicles
  • Electric vehicles
  • Engines
Biotechnology
  • Antibody engineering
  • Antibody manufacture and formulation
  • Bioinformatics
  • Biosimilars
  • Drug delivery
  • Gene editing (e.g. CRISPR)
  • Genomic and molecular tools and methods
  • GM crops
  • Immuno-oncology (e.g. checkpoint inhibitors; modified T cells)
  • Next generation sequencing
  • Nucleic acid synthesis
  • Personalised medicine/disease biomarkers
  • Recombinant protein production and purification
  • Stem cell therapies
  • Supplementary protection certificates (SPCs)
  • Synthetic biology
  • Therapeutic antibodies
  • Vaccinology (e.g. viral vectors; mRNA vaccines)
  • Women’s health products
Chemicals
  • Agrochemicals
  • Catalysts
  • Dispersions and colloids
  • Lubricants
  • Polymers and plastics
Communications and Networks
  • Cloud computing
  • Internet of things (IOT)
  • Oceanography, marine
  • Wired and wireless networks
Computing and Software
  • Artificial intelligence and machine learning
  • Bioinformatics
  • Blockchain and distributed ledgers
  • Communications and networks
  • Computer games
  • Data and software security, cryptography and digital rights management (DRM)
  • Data management and storage, databases and data compression
  • Digital assistants, virtual assistants and software agents
  • Fintech and adtech
  • Machine vision
  • Metaverse, virtual reality (VR) and augmented reality (AR)
  • Motor capture
  • Multimedia, audio/video processing and animation
  • Natural language processing
  • Quantum computing
  • Robotic process automation
  • Search engines
  • Signal processing
  • Software applications and systems, mobile applications, user interfaces
Consumer Goods and Retail
  • Anti-counterfeit devices
  • Beauty
  • Fashion
  • Health, fitness and sport
  • Household goods
  • Luxury goods
  • Moda
  • Retail
Electronics and Electrical Devices
  • Computer and IT architecture and system design
  • Medical devices
  • Optics
  • Restaurants and bars
  • Robotics
  • Scientific instruments
  • Semiconductor devices
  • Testing systems, control systems, signal processing
  • Travel and leisure
  • Wearable tech and human interfaces
Energy and Green Technologies
  • Biofuels
  • Clean air
  • Fuel cells and battery technology
  • Renewables and recycling
  • Solar power
  • Water, oil and gas, nuclear, fusion, fission
  • Wind turbines
Food and Beverage
  • Beverages
  • Nutrition
  • Retail
Industrial Manufacturing and Processing
  • Packaging
  • Polymers and plastics
  • Printing tech
  • Additive manufacturing
  • Coatings
  • Construction
Materials
  • Advanced materials
  • Composite materials
  • Metallurgy and alloys
  • Nanotechnology
Medical Devices and Diagnostics
  • Artificial intelligence
  • Devices
  • Diagnostic instruments
  • Digital health
  • Drug delivery
  • Immuno-oncology
  • In vitro diagnostics
  • Medtech
Pharmaceuticals
  • Diagnostics
  • Drug delivery
  • Generic market entry
  • Medicinal chemistry
  • Methods of production and synthesis
  • Personalised medicine/disease biomarkers
  • Pharmaceutical formulations
  • Pharmaceuticalsceutical formulations
  • Polymorphs
  • Small molecule pharmaceuticals
  • Supplementary protection certificates (SPCs)
Trade Marks
  • Consumer goods
  • Cosmetics and perfumery
  • Financial services
  • Mechanical engineering
  • Mechanical products
  • Services
  • Telecommunications